Clinical Trial Update: ACTH as A Re-emerging theRapy for Uveitis (The ACTHAR Study) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating adrenocorticotropic hormone (ACTH) using ACTHAR for uveitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uveitis

Drugs mentioned

• Acthar Gel (repository corticotropin injection)

Snippet

Sponsor: Quan Dong Nguyen | Conditions: Uveitis | Phase 2 | Status: COMPLETED